المؤلفون: A.S.M. Dofferhof, J. Van Den Berg, J.H.M. van Steijn, A.I.M. Hoepelman, W.C.J. van Veldhuizen, M.C.M. Bunnik, J.H.J.M. Melis, G.J. de Klerk, C.A.J. Hensing, Wiel Geraedts, C.A.J.J. Jaspers, S. Lobatto

المصدر: International Journal of Antimicrobial Agents. 12:121-127

مصطلحات موضوعية: Adult, Male, Microbiology (medical), Chronic bronchitis, medicine.medical_specialty, Adolescent, Exacerbation, Amoxicillin-Potassium Clavulanate Combination, Drug Administration Schedule, Drug Costs, Internal medicine, medicine, Humans, Pharmacology (medical), Bronchitis, Aged, Antibacterial agent, Aged, 80 and over, Respiratory tract infections, business.industry, Ceftriaxone, Pneumonia, General Medicine, Middle Aged, Amoxicillin, Anti-Bacterial Agents, Cephalosporins, Surgery, Infectious Diseases, Chronic Disease, Sputum, Female, medicine.symptom, business, Cefuroxime, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa276ae471fa00b13f0600580be0c4e
https://doi.org/10.1016/s0924-8579(99)00037-0